Vishnuvardhan Reddy
Internal Medicine · Southfield, MINPI 1376522763
Payments from drug & device makers
Across 159 payments — averaging $25.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$945
- Pfizer$626
- GSK$489
- Amgen$312
- Johnson & Johnson$289
- Novo Nordisk$238
- plus $1K from 18 others
What the payments were for
- Food & beverage$4,056100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 31 | $945 |
| Pfizer | 34 | $626 |
| GSK | 17 | $489 |
| Amgen | 13 | $312 |
| Johnson & Johnson | 5 | $289 |
| Novo Nordisk | 13 | $238 |
| Amarin Pharma, Inc. | 6 | $203 |
| Biohaven Pharmaceuticals, Inc. | 2 | $131 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $122 |
| Boehringer Ingelheim | 7 | $107 |
| Astellas Pharma US Inc | 6 | $103 |
| Dexcom, Inc. | 1 | $95 |
| Medtronic | 1 | $77 |
| Kowa Pharmaceuticals America, Inc. | 5 | $65 |
| Merck | 4 | $52 |
| Sanofi-aventis U.S. LLC | 3 | $46 |
| Nevro Corp. | 1 | $31 |
| Lilly USA, LLC | 2 | $28 |
| Abiomed | 1 | $23 |
| AbbVie | 1 | $17 |
| Sanofi | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Circassia Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$494
- TRELEGY ELLIPTA$241
- Vascepa$131
- EUCRISA$125
- Xultophy 100/3.6$122
- AIMOVIG$118
- NURTEC ODT$114
- LifeVest$102
How this compares
$4,056 in reported general payments places this provider in the 85th percentile of 4,567 internal medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 32 | $35,621 |
| EntrestoSacubitril/Valsartan | 13 | $20,589 |
| JardianceEmpagliflozin | 14 | $20,396 |
| Spiriva RespimatTiotropium Bromide | 19 | $14,560 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 75 | $13,145 |
| LinzessLinaclotide | 16 | $12,190 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 65 | $8,797 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 197 | $8,787 |
| SymbicortBudesonide/Formoterol Fumarate | 23 | $8,709 |
| PaxlovidNirmatrelvir/Ritonavir | 16 | $6,406 |
| Atorvastatin Calcium | 466 | $5,521 |
| Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp | 19 | $3,425 |
| Losartan Potassium | 261 | $3,233 |
| Novolog FlexpenInsulin Aspart | 24 | $3,181 |
| Testosterone | 26 | $2,906 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Paxlovid | $626 | $42,02648 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $107 | $34,95633 claims |
| AbbVieLinzess | $17 | $12,19016 claims |
| AstraZenecaSymbicort | $945 | $8,70923 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,567 internal medicine providers in Michigan.
Other internal medicine in Southfield
- Adam FormanSouthfield$524K
- Talal KhaderSouthfield$319K
- Gregory BergerSouthfield$273K
- Ulka VaishampayanAnn Arbor$33.7M
- Jeffrey PottsBay City$14.7M
- Neil FraserTroy$14.3M
- Abdulhassan SaadDearborn$11.5M
- Leslie PelkeyGrand Rapids$8.5M
- Jay SandbergTroy$8.3M
- Ding WangDetroit$6.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.